1 study found for:    16282176 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma
Intervention: Drug: Erlotinib

Indicates status has not been verified in more than two years